Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum GeoVax Labs Inc GOVX

Healthcare Biotechnology
GeoVax Labs, Inc. is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using proprietary platforms. Its product pipeline includes ongoing human clinical trials for a Covid-19 vaccine and a gene-directed therapy against advanced head and neck cancers. Its additional research and development programs include... see more

Bullboard (NDAQ:GOVX)

View:
1 2 Next
Post by whytestockson Nov 26, 2024 11:30pm

GeoVax to Present at the Noble Capital Markets Twentieth Ann

NEWS: $GOVX GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity ConferenceATLANTA, Nov. 26, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a ...more  
27
Post by whytestockson Nov 19, 2024 7:02pm

GeoVax Announces Positive Interim Data Review for Phase 2 Cl

JUST IN: $GOVX GeoVax Announces Positive Interim Data Review for Phase 2 Clinical Trial of COVID-19 Vaccine Booster in Patients with Chronic Lymphocytic LeukemiaGEO-CM04S1 Improved Immune Response vs ...more  
39
Post by whytestockson Oct 02, 2024 10:15pm

GeoVax to Participate in the 3rd Annual ROTH Healthcare Oppo

BREAKING NEWS: $GOVX GeoVax to Participate in the 3rd Annual ROTH Healthcare Opportunities ConferenceATLANTA, Ga., Oct. 02, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology ...more  
51
Post by whytestockson Aug 20, 2024 5:30pm

Presenting on the Emerging Growth Conference 74 Day 1 on Aug

NEWS: $GOVX Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register NowMIAMI, Aug. 20, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal ...more  
56
Post by Nibinatoron Aug 16, 2024 8:04pm

BUY BUY BUY BUY BUY

Officier and directorat David a.dodd buys 8000 shares on 09 08 24
30
Post by whytestockson Aug 15, 2024 12:32pm

GeoVax to Present at the Emerging Growth Conference on Augus

Just In: $GOVX GeoVax to Present at the Emerging Growth Conference on August 21, 2024Company to Discuss Recent Mpox Developments as Well as Milestones Related to the BARDA Project NextGen Award for ...more  
113
Post by Nibinatoron Aug 15, 2024 8:23am

BUY BUY BUY BUY BUY

W.H.O. DEClares state of emergency in africa on monkey pox
167
Post by whytestockson Jul 16, 2024 11:17am

GeoVax to Present at the Emerging Growth Conference on July

Breaking News: $GOVX GeoVax to Present at the Emerging Growth Conference on July 18, 2024Company to Discuss Recent BARDA Project NextGen Award for Its Next-generation COVID-19 Vaccine and Provide ...more  
40
Post by whytestockson Jul 16, 2024 10:47am

Presenting on the Emerging Growth Conference 73 Day 1 on Jul

News; $GOVX Presenting on the Emerging Growth Conference 73 Day 1 on July 17 Register Now | BenzingaMIAMI, July 16, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media ...more  
35
Post by whytestockson Jul 09, 2024 7:30pm

GeoVax Provides First Half 2024 Business Update

Just In: $GOVX GeoVax Provides First Half 2024 Business Update  Award of BARDA Project NextGen contract represents a significant milestone event; total value of award to GeoVax and its CRO ...more  
50
Post by Iseneschalon Jul 01, 2024 11:46am

GOVX.....Ya pays yo money & yo takes yo chances

Might just be a P.O set up.....$3.60 Read this Effective P.O .....Jun 18 https://www.sec.gov/ix?doc=/Archives/edgar/data/832489/000143774924019645/govx20240531_s1.htm
42
Post by whytestockson Jun 27, 2024 10:00am

GeoVax Partners with Allucent to Conduct Phase 2b Clinical S

BREAKING NEWS: $GOVX GeoVax Partners with Allucent to Conduct Phase 2b Clinical Study of Next-Generation COVID-19 Vaccine Candidate with Funding from BARDA10,000-participant randomized Phase 2b study ...more  
53
Post by Nibinatoron Apr 06, 2024 12:47pm

BUY BUY BUY BUY BUY

Got a strong feeling about the porno of fear plan unravelling this is the one ready for roll up
62
Post by Nibinatoron Apr 06, 2024 12:47pm

BUY BUY BUY BUY BUY

Got a strong feeling about the porno of fear plan unravelling this is the one ready for roll up
82
Post by whytestockson Mar 08, 2024 1:00pm

GeoVax Labs, Inc. (NASDAQ: GOVX) Featured in Coverage of the

News; $GOVX GeoVax Labs, Inc. (NASDAQ: GOVX) Featured in Coverage of the 36th Annual Roth ConferenceGeoVax Labs (NASDAQ: GOVX) , is a clinical-stage biotech company committed to developing safe and ...more  
59
1 2 Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities